Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male Volunteers
Clinical trial NCT02273401 · COMPLETED
Trial details
- NCT number
- NCT02273401
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-08-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.